top of page


UK MHRA issues new guidance on accepting non-OECD safety data for clinical trial applications
The UK Medicines and Healthcare products Regulatory Agency has published new guidance allowing case-by-case assessment of certain non-clinical safety data generated outside the OECD Mutual Acceptance of Data framework for clinical trial applications.

nuaxia
Nov 62 min read


FDA finalises guidance on prescription drug companion apps and software labelling
The FDA has issued final guidance clarifying how prescription drug manufacturers should address companion apps and software in product labelling and regulatory submissions.

nuaxia
Oct 212 min read


EMA opens consultation on new guideline for gastrointestinal drug-interaction studies
The European Medicines Agency has opened consultation on a draft guideline addressing the design and interpretation of studies assessing drug absorption interactions within the gastrointestinal tract.

nuaxia
Sep 162 min read


FDA pushes faster generic drug development with 55 new product-specific guidances
The latest regulatory package is intended to reduce uncertainty, development costs and delays for generic manufacturers as the US government increases pressure to bring lower-cost medicines to patients more quickly.

nuaxia
Aug 282 min read


FDA finalises clinical investigation guidance for psychedelic drug development
The guidance gives sponsors clearer recommendations for addressing trial design, safety monitoring, abuse potential and the operational challenges associated with hallucinogenic drug effects.

nuaxia
Jul 303 min read
bottom of page